Retinal Pigment Epithelial Detachment
Information
- Disease name
- Retinal Pigment Epithelial Detachment
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00749021 | Completed | Phase 1 | Ranibizumab for Treating Submacular Vascularized Pigment Epithelial Detachments | September 2008 | August 2012 |
| NCT01628354 | Completed | Phase 4 | Study to Investigate the Safety and Efficacy of Ranibizumab in Patients With Choroidal Neovascularisation Due to Causes Other Than Age Related Macular Degeneration | February 2008 | April 2010 |
| NCT01189019 | Terminated | Phase 2 | HiPED - High Dose Lucentis for Persistent Pigment Epithelial Detachments in Age-related Macular Degeneration | August 2010 | March 2013 |
| NCT01666236 | Withdrawn | Phase 4 | Triple Treatment for Detachment of Retinal Pigment Epithelium Secondary to Polypoidal Choroidal Vasculopathy | September 2012 | September 2014 |
- MedGen concept unique identifier (MedGen Concept name)
- C0339546
- MedGen unique identifier (MedGen Concept name)
- 90942